Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
Public ClinicalTrials.gov record NCT03808688. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label Study of Rhopressa® (Netarsudil Ophthalmic Solution) 0.02% for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the IOP lowering efficacy of netarsudil ophthalmic solution 0.02% when used as monotherapy or when used concomitantly with other IOP-lowering agents in subjects with elevated IOP due to open angle glaucoma or ocular hypertension in a real-world clinical setting. The study is an open-label design. The patients will receive treatment for 12 weeks.
Study identification
- NCT ID
- NCT03808688
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 261 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 26, 2018
- Primary completion
- Jul 25, 2019
- Completion
- Jul 25, 2019
- Last update posted
- Sep 28, 2020
2018 – 2019
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Atlantis Eyecare | Huntington Beach | California | 92647 | — |
| Harvard Eye Associates | Laguna Hills | California | 92653 | — |
| North Bay Eye Associates, Inc | Petaluma | California | 94954 | — |
| Shettle Eye Research Inc | Largo | Florida | 33773 | — |
| Center For Sight | Sarasota | Florida | 34238 | — |
| Coastal Research Associates, LLC | Roswell | Georgia | 30076 | — |
| Wheaton Eye Clinic, Ltd | Wheaton | Illinois | 60187 | — |
| Stiles Eyecare Excellence and Glaucoma Institute, PA | Overland Park | Kansas | 66213 | — |
| Gaddie Eye Centers, LLC | Louisville | Kentucky | 40241 | — |
| Glaucoma Consultants | Baltimore | Maryland | 21204 | — |
| Tekwani Vision Center | St Louis | Missouri | 63128 | — |
| Mark J. Weiss, M.D., Inc. | Tulsa | Oklahoma | 74104 | — |
| Scott & Christie and Associates, PC | Cranberry Township | Pennsylvania | 16066 | — |
| Valley Eye Professionals, LLC | Huntingdon Valley | Pennsylvania | 19006 | — |
| Carolina Cataract & Laser Center | Ladson | South Carolina | 29456 | — |
| Total Eye Care, PA | Memphis | Tennessee | 38119 | — |
| VRF Eye Specialty Group | Memphis | Tennessee | 38120 | — |
| Advancing Vision Research | Nashville | Tennessee | 37204 | — |
| Keystone Research | Austin | Texas | 78731 | — |
| Cataract & Glaucoma Center | El Paso | Texas | 79902 | — |
| Houston Eye Associates | Houston | Texas | 77025 | — |
| The Eye Centers of Racine and Kenosha | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03808688, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2020 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03808688 live on ClinicalTrials.gov.